Inside this episode
- What if NFL owners had to pay taxes on unrealized gains?
- A look at NVDA's remarkable earnings
- NVDA will become the largest company in the world
- It's a stock picker's market
- Buy, sell, or hold BBY after impressive earnings?
- Keep this agriculture stock on your radar
- This retailer is a screaming buy after its selloff
- How to profit from one of the most important growth trends
- Solar names are in freefall—are any of these stocks buys?
- Buffett deserves major credit for this accomplishment
- Avoid this high-flying tech company
- A fantastic trade opportunity on the weight loss craze
This week's trade
Weight loss drugs have taken the world by storm…
And Big Pharma drugmakers aren’t the only ones profiting…
This week’s pick is a small-cap stock that specializes in personalized health & wellness experiences.
The company is putting up tremendous growth numbers. Better yet, it’s turned the corner to profitability. (That’s no small feat for a small cap, particularly in a high-interest-rate environment…)
And its recent foray into weight loss drugs will be a huge growth driver going forward.
Shares have recently pulled back… and now hover around a critical support level. Put simply, if the support holds, it could send the stock back up to recent highs—and hand us a tidy profit in the process.
